Hydroxyurea treatment is associated with reduced degree of oxidative perturbation in children and adolescents with sickle cell anemia

Vinhaes, Caian Leal; Teixeira, Rozana S.; Monteiro Júnior, Jay A. S.; Tibúrcio, Rafael; Cubillos-Angulo, Juan Manuel; Arriaga Gutiérrez, María Belen; Sabarin, Adrielle G.; Souza, Amâncio J. de; Silva, Jacqueline J.; Lyra, Isa M.; Ladeia, Ana Marice Teixeira; Andrade, Bruno de Bezerril.
Artículo en Inglés | ARCA | ID: arc-45499

Documentos relacionados

  1. Healthcare interventions improving and reducing quality of life in children at the end of life: a systematic review.
  2. Role of automated red blood cell exchange in the treatment of aluminum phosphide poisoning: A case report and review of the literature.
  3. Editorial: Placing research in context - what participant and study characteristics should be routinely reported in studies of child and adolescent mental health?
  4. Outcomes of patients who underwent treatment for anti-HLA donor-specific antibodies before receiving a haploidentical hematopoietic cell transplant.
  5. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
  6. Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia.
  7. Hemoglobin F as a predictor of health-related quality of life in children with sickle cell anemia.
  8. Indications for red cell transfusions in pediatric patients.
  9. Desire for biological parenthood and patient counseling on the risk of infertility among adolescents and adults with hemoglobinopathies.
  10. Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.